Contrast-enhanced mammography (CEM) has been gaining traction as a potential screening alternative for dense breasts and high-risk patients, and many institutions are seeking to adopt this modality into their clinical practice. Design and capabilities of commercially available systems will be reviewed along with practical considerations for implementing this technology into the clinical workflow for existing and emerging indications. Digital breast tomosynthesis (DBT) is increasingly used globally as a primary screening modality for breast cancer. The technology is still changing and improving over time, including new detector technologies, faster scanning, and improved reconstruction and image processing. These developments, and the increasing use of AI and machine learning at nearly every stage of the DBT workflow, will be discussed. Numerous clinical studies demonstrating the clinical utility of dedicated breast CT (bCT) will be explained and summarized in the context of comparison to standard-of-care breast imaging techniques. Limitations of existing bCT technology will be reviewed, and next generation developments aimed at overcoming some of these challenges and expanding the utility of the modality will be presented.
For ongoing education and resources, please visit RSNA Course Catalog.
Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:
- Breast (Imaging and Interventional)
- Computed Tomography
- Physics and Basic Science
- Research and Statistical Methods
Learning Objectives:
- Explore the emerging role of contrast-enhanced mammography (CEM) in breast cancer screening, diagnosis, and biopsy, and discuss considerations and hurdles to clinical implementation.
- Discuss the latest developments in software and hardware technology in clinical and research digital breast tomosynthesis (DBT) systems and the emerging role of machine learning/AI on DBT workflow, computer-aided diagnosis, reconstruction, dose reduction, and risk prediction.
- Describe the proven clinical utility of dedicated breast CT (bCT) for breast cancer diagnosis, the next-generation developments in bCT, and how they may further enhance clinical utility of this modality.
This enduring material is estimated to take 1 hour to complete.
Start Date: 3/18/2026
End Date for CME Eligibility/Online Expiration Date: 3/17/2029
This educational activity was originally presented at the RSNA 2025 Annual Meeting and Scientific Assembly.
Faculty:
- Andrew Hernandez, PhD
- Katie Hulme, MS
- James Mainprize, PhD
- Ioannis Sechopoulos, PhD
Planners:
- Jenny T. Bencardino, MD
- Guillermo Elizondo-Riojas, MD, PhD
- Marta E. Heilbrun, MD
- Ayden Jacob, MD, MSc
- Bertram J. Stemmler, MD
- Meike W. Vernooij, MD
- Grace G. Zhu, MD
Disclosure Statements:
RSNA controls the planning, development, and delivery of this CME activity and will strictly adhere to the Standards for Integrity and Independence in Accredited Continuing Education established by the Accreditation Council for Continuing Medical Education (ACCME).
Listed below are all the financial relationships provided by individuals in a position to influence and/or control CME activity content. All financial relationships listed for these individuals have been mitigated. Please note that any individuals not listed below have reported no financial relationships (currently or within the past 24 months). The ACCME defines any ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare, products used by or on patients."
Faculty:
- A. Hernandez: Consultant; Izotropic Corporation.
- J.G. Mainprize: Grant/Research Support; GE Healthcare. Owner; Calavera Surgical Design Inc.
- I. Sechopoulos: Grant/Research Support; Siemens Healthcare, Canon Medical, ScreenPoint Medical, Volpara Healthcare, Sectra Benelux, Hologic Inc., iCAD, Lunit. Other - Scientific Advisory Board member; Koning Corp.
Planners:
- Ayden Jacob, MD, MSc: Consultant, Aidoc.
Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
RSNA designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Credit Information:
To earn CME credit, participants must watch the full length of the recording and complete the course evaluation.
Price:
Non-Member/Basic Member Rate: $55.00
Standard Member/Full Access Member Rate: $0.00
Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.
RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.